StockData
LivaNova PLC logo

LivaNova PLC (LIVN) stock

LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3021% above fair value
$94.54+2.62 (+2.85%)

Close on Nov 18, 2026Market cap $5.21BP/E 27.9Yield –

LivaNova price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

LivaNova's price to sales ratio was 3.4× on Nov 11, 2026, against 2.6× a year earlier. Over the last 5 years it ranged from 1.6× to 4.5×, with a median of 2.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.4×+0.9
2025Dec 31, 20252.5×+0.5
2024Dec 31, 20242.0×−0.5
2023Dec 29, 20232.5×−0.4
2022Dec 30, 20222.9×−1.6
2021Dec 31, 20214.5×+1.1
2020Dec 31, 20203.4×+0.0
2019Dec 31, 20193.3×−0.8
2018Dec 31, 20184.1×−9.1
2017Dec 29, 201713.2×+9.2
2016Dec 30, 20164.0×−1.3
2015Dec 31, 20155.3×+0.3
2014Dec 31, 20145.0×−1.9
2013Dec 31, 20136.9×–

More LivaNova figures

See a number that looks wrong?